We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Studio Pictures Ltd is a UK-based film and TV production company founded by producers Adam Rolston and David Braithwaite in 2019. Specializing in creating high-quality British entertainment content, the company focuses on adapting books to screen and telling unique true-life stories that entertain and inspire both domestic and international audiences. With successful productions like "A Street Cat Named Bob," the company is building a strong brand and reputation in the industry. Studio Pictures has access to top creative talent and collaborates with major studios like Warner Bros, Sony Pictures, Lionsgate, and Studio Canal. The company is located at Twickenham Studios in Richmond, UK.
days to go: 16 investment: Withheld
Qure are an affordable and convenient on-demand healthcare service providing a doctor to users doors within 2 hours, 24/7. The hassle-free healthcare connects individuals with highly-experienced medical practitioners in the local area. 
days to go: Expired investment: £720,000
The Ticket Bank (TTB) is an online ticketing marketplace that provides event tickets to disadvantaged and marginalised individuals free of charge. The company is powered by 'Tickets for Good'. It works with event organisers, charities, and community organisations to distribute otherwise unused event tickets to beneficiaries, creating unique life experiences that provide wide-ranging benefits to the health and wellbeing of its target audience. The platform already supports over 500+ charity partners who can choose tickets from over 50 venues/entertainment partners. The company introduced the 'Virtual Ticket Bank' and 'The Giving Back campaign' in the COVID-19 pandemic wherein it is sourcing thousands of tickets for National Health Service (NHS) and frontline care workers to express its gratitude for their services. They can use these tickets when the lockdown is over. The company will use the investment to create the integrations and data gathering tools to rapidly grow its channels, as well as, create additional value for both its charity and venue clients.

Pitch Rated

45%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £145,246
Netflix, Inc. is an American media service provider and production company founded in 1997 by Reed Hastings and Marc Randolph in Scotts Valley, California. It has 100 million members in over 190 countries enjoying more than 125 million hours of TV programmes and films per day. In 2017, the company's project 'The White Helmets' won the Academy Award for Best Documentary (Short Subject). For the fiscal year 2019, the company's annual net income was $1.9 billion, up 54.1% Year-over-Year (YOY). The company has won a list of accolades such as the Academy Awards, Golden Globe Awards, BAFTA Film Awards, Grammy Awards, and Daytime Emmy Awards, to name a few. It will use the investment to grow its business across different verticals. 
days to go: Expired investment: £844,200
Fubar radio is a digital media entertainment brand that reaches millions of 18-34 year olds using original video, audio and social media content. Furbar Radio produces edgy and fun content thats available everywhere and on any device.
days to go: Expired investment: £307,250
Run3D is a biotechnology company that has developed a 3D gait analysis system with the aim to help people identify injuries, deliver better performance, and make better running decisions. 3D gait analysis involves using infrared cameras to track positions of small reflective markers attached to a person in motion, capturing measurable data to help quantify a person's risk of injury, biomechanical efficiency, performance, footwear, and recommend proper diagnosis where necessary. The company plans to use the investment to grow its business.
days to go: Expired investment: Withheld
Walljam is a sports technology business that is digitising ball sports through its advanced, smart panel technology. The company's latest offering, 'Metrix', is the first football-themed social entertainment venue launched in partnership with UEFA Champions League. Walljam intends Metrix to be the turning point in the company's image from a purely fan engagement platform to a social entertainment and live events operator. Metrix's inaugural venue will open in Autumn 2020 at Westfield London (White City), Europe’s largest shopping mall. Under the UEFA Global Licensing Partnership, nine more venues are expected to open across Europe within the next five years. The company is seeking to raise funds of £3.5 million at a pre-money valuation of £3.6 million. It will use the investment to launch the first Metrix venue and manage working capital.
days to go: Expired investment: £577,132
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph